Such acquisition is the first time in the history of the UK’s CBD community.
Taylor Mammon is a UK-based CBD manufacturer and distributor. The company specializes in white label manufacturing and brand distribution. It recently got acquired by GenCanna, a Kentucky-based producer of hemp-derived CBD and other cannabinoids. GenCanna is in fact the leading company in the THC-free CBD market.
Both organisations believe that this union will continue the successful three-year relationship they have been having in which GenCanna will keep supplying Taylor Mammon with primary source of CBD.
Commenting on the news, Nathan Wogman, co-founder and Managing Director of Taylor Mammon said:
“We are delighted with the opportunity this acquisition affords us.
“GenCanna’s acquisition of Taylor Mammon positions us for significant international growth and to be a global leader in the CBD arena.
“Our partnership provides us with the financial and intellectual capital and discipline to accelerate our growth through product innovation, contract manufacturing, fulfillment, and distribution services.”
GenCanna CEO, Andrew Barnett, added:
“This alliance — which we understand is the first of its kind for a UK-based CBD company — drives unique and mutually beneficial operational and marketing synergies that will catapult product development, sales, and revenue opportunities within our respective geographies.”
In fact, the acquisition comes after an 18-month initiative from Taylor Mammon to prepare for its Novel Foods Application at a UK and EU level.
